TERESANN NICKLE: Open Payments
NPI 1831245786 · GUADALUPE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 23 payments from 9 companies in 2025. Trend: 2023 $14 · 2024 $632 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $207 |
| Neurocrine BioSciences, Inc. | 2 | $160 |
| Novo Nordisk Inc | 1 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Lilly USA, LLC | 2 | $34 |
| ABBVIE INC. | 2 | $30 |
| Corium, LLC | 2 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: CAPLYTA, INGREZZA, Wegovy, REXULTI, VRAYLAR, Azstarys, Kerendia, Auvelity.
Industry payments across CA — which companies pay providers there.
